0001140361-21-009200.txt : 20210318
0001140361-21-009200.hdr.sgml : 20210318
20210318211408
ACCESSION NUMBER: 0001140361-21-009200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210315
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldman Neil A
CENTRAL INDEX KEY: 0001726644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35569
FILM NUMBER: 21756258
MAIL ADDRESS:
STREET 1: 3661 HORSEBLOCK RD
CITY: MEDFORD
STATE: NY
ZIP: 11763
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC.
CENTRAL INDEX KEY: 0001092662
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880425691
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
BUSINESS PHONE: (631) 924-1135
MAIL ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
FORMER COMPANY:
FORMER CONFORMED NAME: Chembio Diagnostics Inc.
DATE OF NAME CHANGE: 20040607
FORMER COMPANY:
FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC
DATE OF NAME CHANGE: 19990805
4
1
form4.xml
FORM 4
X0306
4
2021-03-15
0001092662
CHEMBIO DIAGNOSTICS, INC.
CEMI
0001726644
Goldman Neil A
C/O CHEMBIO DIAGNOSTICS, INC.
555 WIRELESS BOULEVARD
HAUPPAUGE
NY
11788
true
See Remarks
Restricted Stock Units
2021-03-15
4
A
0
38710
0
A
Common Stock
38710
38710
D
Incentive Stock Options
4.65
2021-03-15
4
A
0
107143
0
A
2028-03-14
Common Stock
107143
107143
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
The restricted stock units are scheduled to vest over three years, with one-third vesting on March 15, 2022, one-third vesting on March 15, 2023, and the remaining one-third vesting on March 15, 2024, subject to continued service through each vesting date.
The incentive stock options are scheduled to vest and become exercisable over four years, with one-fourth vesting on March 15, 2022, one-fourth vesting on March 15, 2023, one-fourth vesting on March 15, 2024 and the remaining one-fourth vesting on March 15, 2025, subject to continued service through each vesting date.
Executive Vice President, Chief Financial Officer
/s/ Mark L. Johnson, Attorney-in-Fact for Neil A. Goldman
2021-03-18